High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies | Science Translational Medicine
Binding potency of broadly reactive anti-alphavirus antibodies to infected cells dictates the requirement for Fc-mediated protection in vivo.
